Clinical Trials Directory

Trials / Sponsors / Tisento Therapeutics

Tisento Therapeutics

Industry · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Enrolling By InvitationAn Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)
Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
Phase 22025-08-18
Active Not RecruitingA Phase 2b Study of Zagociguat in Patients With MELAS
Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
Phase 22024-09-10
TerminatedA Study of the Effects of CY6463 in Participants With Alzheimer's Disease With Vascular Pathology
Alzheimer's Disease With Vascular Pathology
Phase 22021-11-02
CompletedStudy to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia
Schizophrenia
Phase 12021-09-10
TerminatedPhase 2a Study of IW-6463 in Adults Diagnosed With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Strok
MELAS
Phase 22020-11-13
TerminatedIW-6463 Safety Study in Healthy Elderly Subjects
Other
Phase 12020-01-06
CompletedA Study of IW-6463 in Healthy Volunteers
Other
Phase 12019-02-06